Literature DB >> 12495783

Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling.

Kazuhiko Tamura1, Masahiro Okazaki, Masahito Tamura, Kazuhiko Isozumi, Hiromi Tasaki, Yasuhide Nakashima.   

Abstract

Urotensin II (UII), a cyclic dodecapeptide, is a potent mammalian vasoconstrictive substance recently shown to induce proliferation of vascular smooth muscle cells (VSMCs). However, little is known about mechanisms involved in UII-induced mitogenic response such as cell proliferation. To investigate the intracellular signaling pathways involved in this process, we examined the effects of UII on activation of extracellular signal-regulated kinase (ERK) and focal adhesion kinase (FAK) in VSMCs. UII stimulated in time- and dose-dependent manners the phosphorylation level of ERK. In contrast, UII failed to alter the phosphorylation level of FAK. Although angiotensin II-induced ERK phosphorylation was noted even in suspended cells, UII failed to induce an increase in ERK phosphorylation in such cells. On the other hand, UII induced an increase in the phosphorylation level of ERK, but not FAK, in cells adherent to fibronectin. Furthermore, UII-induced proliferation of VSMCs was inhibited by ERK kinase inhibitor PD98059. Our results suggested that activation of integrin-mediated signaling pathways play a critical role in UII-induced phosphorylation of ERK, leading to proliferation of VSMCs, which does not involved increased phosphorylation of FAK.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12495783     DOI: 10.1016/s0024-3205(02)02346-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  11 in total

1.  Urotensin upregulates transforming growth factor-β1 expression of asthma airway through ERK-dependent pathway.

Authors:  Wei-Xi Zhang; Ya-Feng Liang; Xiao-Ming Wang; Ying Nie; Lei Chong; Li Lin; Chun Chen; Chang-Chong Li
Journal:  Mol Cell Biochem       Date:  2012-01-21       Impact factor: 3.396

2.  Enhancement of vascular smooth muscle cell migration by urotensin II.

Authors:  Satoshi Matsusaka; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

Review 3.  The role of urotensin II in cardiovascular and renal physiology and diseases.

Authors:  Yi-Chun Zhu; Yi-Zhun Zhu; Philip Keith Moore
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

4.  Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells.

Authors:  Myriam Iglewski; Stephen R Grant
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

5.  Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium.

Authors:  Fernando S Carneiro; Zidonia N Carneiro; Fernanda R C Giachini; Victor V Lima; Edson Nogueira; William E Rainey; Rita C Tostes; R Clinton Webb
Journal:  J Am Soc Hypertens       Date:  2008-11

6.  A closer look at the role of urotensin II in the metabolic syndrome.

Authors:  Pierre-Olivier Barrette; Adel Giaid Schwertani
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-28       Impact factor: 5.555

7.  Potential Clinical Implications of the Urotensin II Receptor Antagonists.

Authors:  Philip Tsoukas; Emilie Kane; Adel Giaid
Journal:  Front Pharmacol       Date:  2011-07-22       Impact factor: 5.810

8.  Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway.

Authors:  Hui Gong; Zhidan Chen; Xiaoyi Zhang; Yang Li; Jie Zhang; Ying Chen; Yingjiong Ding; Guoping Zhang; Chunjie Yang; Yichun Zhu; Yunzeng Zou
Journal:  Int J Mol Sci       Date:  2015-06-03       Impact factor: 5.923

9.  Effect of urotensin II on apolipoprotein B100 and apolipoprotein A-I expression in HepG2 cell line.

Authors:  Abbas Mohammadi; Ahmad Gholamhoseinian Najar; Amirhosein Khoshi
Journal:  Adv Biomed Res       Date:  2014-01-09

10.  Urotensin II promotes atherosclerosis in cholesterol-fed rabbits.

Authors:  Yafeng Li; Sihai Zhao; Yanli Wang; Yulong Chen; Yan Lin; Ninghong Zhu; Huadong Zheng; Min Wu; Daxing Cheng; Yandong Li; Liang Bai; Jianglin Fan; Enqi Liu
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.